SUBSCRIBE
SUBSCRIBE
News   Deals

Amylin Pharmaceuticals, Inc. Says Icahn Trying to Sell Company to Eli Lilly and Company

April 20, 2009 | 
1 min read
NEW YORK, April 20 (Reuters) - Billionaire investor Carl Icahn wants to engineer a sale of biotechnology company Amylin Pharmaceuticals Inc (AMLN.O) to its diabetes partner Eli Lilly and Co (LLY.N), according to Amylin.
Mergers & acquisitions
Eli Lilly and Company
MORE ON THIS TOPIC
A contemporary art collage depicting a giant ear listening to a message bubble while covering it with a hand. The concept of taking in a useful experience or overhearing a new idea.
Gene editing
Lilly Leans Into Hearing Loss in $1.12B+ Gene Editing Pact With Seamless
January 28, 2026
 · 
2 min read
 · 
Tristan Manalac
Pictured: Boehringer Ingelheim's office in California
Inflammatory bowel disease
Boehringer Commits up to $1.26B in IBD Pact With China’s Simcere
January 27, 2026
 · 
2 min read
 · 
Tristan Manalac
Hand Serving Stack Of Dollar coin Bills On Platter To A Businessman
Mergers & acquisitions
Revolution Knows Its Worth as Merck Backs Off—For Now
January 26, 2026
 · 
4 min read
 · 
Annalee Armstrong
Two hands locked in a handshake cut by a pair of scissors, symbolizing a severed relationship or partnership. Black and white collage illustration on paper textured background
Mergers & acquisitions
Merck Backs Off Revolution After Failing To Agree on Price: WSJ
January 26, 2026
 · 
1 min read
 · 
Tristan Manalac